The assisted reproductive technology (ART) market was valued at USD 25.07 billion in 2025 and is expected to grow at a compound annual growth rate (CAGR) of 6.50% from 2026 to 2035. By 2035, the market is projected to reach USD 47.06 billion. The growth is primarily driven by the increasing demand for fertility treatments, advancements in ART technologies, and rising awareness around assisted reproduction solutions for couples struggling with infertility.Assisted Reproductive Technology Market Size
In 2025, the ART market was valued at USD 25.07 billion. ART includes medical procedures and technologies used to treat infertility, such as in-vitro fertilization (IVF), sperm/egg donation, and embryo freezing. The market encompasses a wide range of products and services, including fertility medications, IVF culture media, embryo incubators, and diagnostic tools.
Assisted Reproductive Technology Market Trends
Advancements in IVF and Fertility Treatments: Ongoing technological innovations are significantly improving the success rates of fertility treatments. IVF, along with procedures like ICSI (intracytoplasmic sperm injection), is becoming more effective due to enhanced laboratory techniques, improved embryo culture media, and advanced monitoring tools.
Growing Popularity of Egg and Sperm Freezing: As more individuals delay starting families for personal or professional reasons, the demand for egg and sperm freezing has risen. Freezing gametes allows people to preserve their fertility for future use, contributing to the growth of the ART market.
Assisted Reproductive Technology Market Growth
Rising Incidence of Infertility: The growing prevalence of infertility, particularly among women over 35, is a key driver of the ART market. Factors like lifestyle changes, delayed marriage, and increasing health conditions such as polycystic ovary syndrome (PCOS) and endometriosis contribute to higher demand for fertility treatments.
Increased Awareness and Acceptance: As the stigma surrounding infertility decreases, more people are seeking ART solutions. Additionally, greater awareness about fertility preservation methods and advancements in ART has led to higher demand for services.
Assisted Reproductive Technology Market Forecast
The ART market is expected to grow at a CAGR of 6.50% from 2026 to 2035, reaching a value of USD 47.06 billion by 2035. The increasing demand for fertility treatments, combined with ongoing advancements in ART technologies, will drive the market's expansion.
Get a Free Sample Report with Table of Content
Competitive Analysis
CooperSurgical, Inc.: CooperSurgical offers a variety of ART solutions, including fertility diagnostics, IVF equipment, and embryo cryopreservation products. Its strong portfolio in reproductive health has made it a key player in the global ART market.
Others: Several other companies, including regional players and fertility clinics, contribute to the ART market by offering specialized products and services. These players are focusing on providing affordable, effective, and personalized fertility treatments to meet the diverse needs of patients.